NADPH oxidase 1 (Nox1) is a member of the NADPH oxidase family that has not been well characterized in the melanocytic cell lineage. Here we demonstrated that Nox1 and Nox4 were detected in melanocytic lineage, with only Nox1 detected in normal human melanocytes and Nox4 in a subset of metastatic melanoma cell lines. The protein level and enzymatic activity of Nox1 was elevated in all melanoma cells as compared with normal melanocytes. Overexpression of GFP-Nox1 protein in Wm3211 primary melanoma cells increased invasion rate by 4-to 6-fold as measured by Matrigel invasion assay, whereas knocking down or inhibiting Nox1 decreased invasion by approximately 40-60% in Wm3211 and SK-Mel-28 cells. Matrix metalloproteinase-2 (MMP-2) was increased by Nox1 overexpression at the mRNA, protein, and activity levels, and decreased by Nox1 knockdown. MMP-2 promoter activity was also regulated by Nox1 knockdown. In addition, stable clones overexpressing Nox1 exhibited an epithelial-mesenchymal transition (EMT) as examined by cell morphology and EMT markers; knockdown or inhibiting Nox1 led to a reversal of EMT. Supplementing MMP-2 to culture media did not induce EMT, suggesting that EMT induction by Nox1 was not through MMP-2 upregulation. In summary, Nox1 was overexpressed in all melanoma cell lines examined, and enhanced cell invasion by MMP-2 upregulation and EMT induction.
INTRODUCTION
NADPH oxidase (EC 1.6.3.-) is a family of enzymes that catalyze transfer of an electron from NAD(P)H to molecule oxygen to generate superoxide or hydrogen peroxide. It consists of seven members, represented by their catalytic subunits: NADPH oxidase 1 (Nox1), Nox2 (gp91phox), Nox3, Nox4, Nox5, Duox1, and Duox2. These enzymes are expressed differentially in various tissues and organs (Lambeth, 2004; Sumimoto, 2008) . Nox2 is the founding member of this enzyme family that has been extensively studied in phagocytes and cardiovascular cells (Giannopoulou et al., 2008; Krause and Bedard, 2008; Rada et al., 2008) . Nox1 is the enzyme closest to Nox2 in a phylogenetic tree of this family (Kawahara and Lambeth, 2007) .
Nox1 requires a membrane subunit p22phox, Noxa1, and Noxo1 for its full activity (Banfi et al., 1999; Ambasta et al., 2004; Hanna et al., 2004) . Nox1 is expressed in colon epithelial cells, vascular smooth muscle cells, endothelium, uterus, placenta, prostate, osteoclasts, and retinal pericytes, and serves as an important signal molecule downstream of platelet-derived growth factor, angiotensin II, and tumor necrosis factor-a (Brown and Griendling, 2009) . Recently, overexpression of Nox1 was reported in colon cancer, gastric cancer, and prostate cancer (Suh et al., 1999; Kamata, 2009 ). To our best knowledge, expression of Nox1 was not reported in melanoma, although expression of Nox4 has been reported previously (Brar et al., 2002; Govindarajan et al., 2007; Yamaura et al., 2009 ).
An early study revealed that Nox1 overexpression induced transformation in NIH3T3 cells (Suh et al., 1999) ; subsequent studies showed that Nox1 was required for K-ras-mediated transformation of normal rat kidney cells (Komatsu et al., 2008) . Hence, Nox1 plays an important role in cancer development. In colon cancer cells, reactive oxygen species (ROS) generated by Nox1 contributed to cell invasion through upregulating matrix metalloproteinase-9 (MMP-9) (Shinohara et al., 2010) . MMPs are a family of proteinases with various substrates and functions, including angiogenesis, tissue invasion, inflammation, and tumor metastasis (HadlerOlsen et al., 2010; Kessenbrock et al., 2010) . In melanoma, both MMP-2 and MMP-9 were involved in cell invasion (van den Oord et al., 1997; Simonetti et al., 2002) ; however, only overexpression of MMP-2 is correlated with progression and survival (Vaisanen et al., 1998 (Vaisanen et al., , 2008 Orimoto et al., 2008; Malaponte et al., 2010) . To our best knowledge, regulation of MMP-2 by Nox1 has not been reported in cancer cells including melanoma.
Epithelial-mesenchymal transition (EMT) is a pathway facilitating cell invasion, which is characterized by loss of epithelial and gain of mesenchymal morphology, accompanied by loss of E-cadherin, gain of N-cadherin, vimentin, and other markers (Pla et al., 2001; Singh and Settleman, 2010) . MMP-3 and MMP-9 may contribute to EMT via modifying the extracellular matrix components (Radisky et al., 2005; Blavier et al., 2010) ; whether MMP-2 played such a role is not clear. Although Nox1 played a role indirectly in modifying cell adhesion molecules (Sadok et al., 2009) , it is not clear whether Nox1 mediates EMT process.
RESULTS

Nox1 is overexpressed in melanoma cell lines
The Nox1 expression levels and total Nox activities in normal human melanocytes (NHMs) and melanoma cell lines were examined. As shown in Figure 1a , compared with NHMs, Nox1 protein levels were increased in all melanoma cell lines. Figure 1b shows the densitometry-quantified Nox1 protein levels (first normalized to a-tubulin loading control and then to NHMs). Figure 1c shows total Nox enzymatic levels as analyzed using NADH as a substrate and lucigenin as the electron acceptor for superoxide anions (Cui and Douglas, 1997; Cai et al., 2007) . All melanoma cell lines exhibited higher Nox activities than NHMs. This enzyme assay does not distinguish among Nox family members; hence, it reflects total Nox activity based on superoxide generation. Therefore, reverse transcriptase-PCR (RT-PCR) was performed to identify individual Nox members. As shown in Figure 1d , Nox1 mRNA was detected in normal melanocytes and all melanoma cell lines examined. Consistently, mRNAs for Nox1 subunits Noxo1 and p22phox were also detected in NHMs and melanoma cell lines. In contrast, Nox4 mRNA was not detected in NHMs or primary melanoma cell lines Wm3211 and Wm115 ( Figure 1d) ; instead, it was only detected in three metastatic cell lines A375, c8161, and c8146A ( Figure 1d ). The HaCaT cells and human umbilical vein endothelial cells were used as positive controls for Nox1 and Nox4, whereas b-actin was used as a loading control. We further examined the mRNA accumulation of all seven members of Nox family in NHMs and c8146A melanoma cell lines and confirmed again that the only two members expressed in melanocytic lineage were Nox1 and Nox4, whereas only Nox1 mRNA was detected in NHMs (Figure 1e ).
Subcellular localization of Nox1
To determine the subcellular localization of Nox1, a GFPtagged Nox1 construct pEGFP-Nox1 was generated and transfected into Wm3211 cells. Two stable clones (Clone nos. 0 ,6-diamidino-2-phenylindole (DAPI) and plasma-membrane marker wheat-germ agglutinin (WGA) (Flesch et al., 1998) conjugated with Texas Red revealed that the Nox1 signal was mainly localized in the cytosolic compartment, with minor signal overlapping with WGATexas Red fluorescence ( Figure 2b ). When examined under a microscopy with Â 63 objective oil lens, the cytosolic and partial plasma-membrane localization was more obvious (Figure 2c ). No GFP-Nox1 signal was observed in the nucleus (Figure 2c ). The cytosolic and partial plasma-membrane localization of Nox1 was further confirmed by immunofluorescence using anti-Nox1 antibody and FITC-conjugated secondary antibody. The majority of the Nox1 green fluorescence was within the cytosol, and again a portion of the signal was on the plasma membrane ( Figure 2d ).
Overexpression of Nox1 in Wm3211 cells led to increased invasion
As shown in Figure 2 , overexpression of GFP-Nox1 showed green fluorescence signal in a pattern distinct from that of GFP alone; however, we were unable to detect the GFP-Nox1 protein on a western blot, presumably due to low levels of expression of this fusion protein, or disruption of the epitope recognized by the antibody. Yet, when total Nox activity was measured, both no. 1 and no. 2 cells showed higher level (3B8-fold) compared with the parental Wm3211 cells (Figure 3a) . Consistently, these clones also exhibited higher levels of superoxide (2.5-to 3.1-fold) as measured by dihydroethidium fluorescence (Figure 3b ). To examine whether Nox1-mediated ROS has a particular role in melanoma invasion, Matrigel invasion assay was performed. As shown in Figure 3c and d, Clone nos. 1 and 2 showed 3.6-and 4.5-fold higher invasion rate than the control Wm3211 cells, whereas the negative control GFP clone did not show a significant increase of invasion. To rule out clone variation, GFP-Nox1 was transiently expressed in Wm3211 cells and the invasion rate was compared with that in cells overexpressing GFP alone. GFP signal was verified using a fluorescence microscope ( Figure  3e www.jidonline.org 2035 F Liu et al.
Nox1 in Melanoma Invasion
Knocking down or inhibiting Nox1 led to decreased invasion
To further confirm the role of Nox1 in melanoma invasion, melanoma cells were pretreated with a Nox inhibitor diphenyl-iodonium chloride (DPI) at 5 mM for 4 hours before invasion assay. DPI treatment decreased the number of invaded cells for both Wm3211 and SK-Mel-28 (Figure 4a and b) . Furthermore, plasmids expressing shorthairpin RNAs targeting two different sequences in Nox1 coding region were constructed (pRS-sh2 and pRS-sh3) and transfected into Wm3211 and SK-Mel-28 cells, and then selected with puromycin for 2 weeks. The shRNA targeting GFP sequence (pRS-GFPi) was used as a control. Nox1 protein knockdown (70-80%) was confirmed by western blot in both cell lines (Figure 4c ). Decreased invasion rates (40-60%) were observed in both cell lines transfected with either pRS-sh2 or pRS-sh3 plasmids, as compared with the control cells (Figure 4d and e).
Nox1 regulates MMP-2
MMP-2 and MMP-9 are among the MMPs characterized in melanoma cells for their key roles in invasion (Leslie and BarEli, 2005) . We examined the expression levels of both MMPs in response to Nox1 regulation. As shown in Figure 5a , the gelatinase activity assay indicated that the 72-kDa MMP-2 activity increased in culture media of Clone no. (Figure 5a ). The MMP-9 activity was not detected in these cells (Figure 5a ). Quantification by densitometry indicated that the MMP-2 activity increased about 4-to 5-fold in Clone nos. 1 and 2, and then decreased about 50% in sh2 and sh3 cells (Figure 5a ). Western blot analysis confirmed that in Clone nos. 1 and 2, the secreted MMP-2 protein accumulated to higher levels than that in the control Wm3211 cells, and lower levels in sh2 and sh3 cells (Figure 5b ). Duplicated gels stained with Coomassie blue (partial) is shown as loading controls (Figure 5b) . In SK-Mel-28 cells with Nox1 knockdown (sh2 and sh3), MMP-2 activity was also decreased about 50-70% as compared with the control parental cells (Figure 5c ). Quantitative RT-PCR analysis indicated that the MMP-2 mRNA increased about 10-fold in Clone no. 1 and no. 2 cells as compared with that in the parental cells. A small increase (2.5-to 3.5-fold) of MMP-9 mRNA was also observed in these cells (Figure 5d ). Overexpression of Nox1 was further confirmed in these clones as the Nox1 mRNA accumulated to about 5-to 19-fold in Clone nos. 1 and 2 as compared with Wm3211 cells (Figure 5d) . Analysis of the MMP-2 promoter reporter activity in sh2 and sh3 cells indicated that the knockdown of Nox1 decreased MMP-2 promoter activity by 30-40% (Supplementary Figure S1a online). These data suggest that regulation of MMP-2 by Nox1 is likely through a transcriptional mechanism. As MMP-2 is a well-documented transcriptional target for AP-1 transcriptional factors, we also examined the AP-1 transcription activity in Clone no. 1 and no. 2 cells. A reporter plasmid for AP-1 activity, pAP-1-SEAP, was transiently transfected into Wm3211 cells together with pRL-SV40 luciferase reporter plasmids (internal control). Our results showed that normalized AP-1 activities in Clone nos. 1 and 2 were about 2.5-to 4.0-fold of that in the parental Wm3211 cells (Supplementary Figure S1b online ). Further examination of AP-1 transcription factors in Nox1 overexpression clones indicated that among all AP-1 members, only JunB showed increased protein accumulation in Clone no. 1 and no. 2 cells (data not shown). Chromatin immunoprecipitation experiments using antibody against JunB showed that binding of JunB to MMP-2 promoter decreased in sh2 cells to nearly background level and increased about 2-fold in Nox1-overexpressing Clone no. 1 cells (Figure 5e ).
To further confirm that Nox1-generated ROS and upregulated MMP-2 played key roles in its ability to stimulate invasion, Clone no. 1 cells were treated with the ROS scavenger N-acetyl-cysteine (NAC, 2 mM, 24 hours) or MMP inhibitor GM6001 (10 mM, 4 hours) before invasion assay. Our results showed that both NAC and GM6001 reduced invasion rate in these cells, by approximately 67 and 50%, respectively (Figure 5f and g ). Zymography assay indicated that NAC treatment led to a decreased (about 65%) MMP-2 activity in Wm3211 cells (Figure 5h ). Quantitative RT-PCR 
Nox1 regulates EMT
In addition to MMPs, EMT also plays an important role in cell migration and invasion. We observed that Clone nos. 1 and 2 showed an elongated, mesenchymal morphology as compared with the parental Wm3211 cells (Figure 6a ), which mimicked a transforming growth factor-b-induced EMT morphological change ((Supplementary Figure S3a online) . Western blot analysis indicated that EMT markers N-cadherin and vimentin were increased in Clone no. 1 and no. 2 cells as compared with Wm3211 cells, and E-cadherin decreased (Figure 6b ). In contrast, Wm3211 cells with Nox1 knockdown (sh2 and sh3 cells) showed a reversed EMT morphology: the cells were more epithelial-like as compared with the control GFPi cells (Figure 6c ). Consistently, western blot analysis showed that the sh2 and sh3 cells exhibited reversed EMT marker changes: increased E-cadherin and decreased N-cadherin and vimentin (Figure 6d ). Furthermore, when Nox1 was inhibited by DPI in SK-Mel-28 cells, these cells also showed a dose-and time-dependent reversal of EMT phenotype (Figure 6e ). Western blot analysis indicated that N-cadherin and vimentin were decreased, and E-cadherin increased in the DPI-treated cells as compared with control cells (Figure 6f ). Knocking down Nox1 in SK-Mel-28 cells led to similar reversed EMT morphological changes where cells became flatter, less elongated, and more epithelial-like (Supplementary Figure S4 online ). It was reported that some MMPs were able to induce EMT in certain cell lineages (Tan et al., 2010; Lin et al., 2011) . To test whether Nox1-upregulated MMP-2 played a role in EMT induction in Wm3211 cells, we added purified active MMP-2 into cell culture media and incubated for up to 48 hours; no induction of EMT was observed (Supplementary Figure S3b online ).
DISCUSSION
The Nox gene family plays key roles in regulating many physiological processes including cardiovascular function and immune responses. An early study identified that Nox4 played a role in melanoma proliferation (Brar et al., 2002) . A few studies subsequently confirmed the role of Nox4 in melanoma cell cycle progression and invasion (Govindarajan et al., 2007; Yamaura et al., 2009) . Expression of other Nox family members was not reported, although Nox enzyme activity was shown to be important for melanoma cell differentiation (Zhao et al., 2008) . In this study, we report expression of Nox1 and its subunits p22phox and Noxo1 in normal human melanocytes and melanoma cell lines, and characterized its function in promoting melanoma invasion via upregulating MMP-2 and induction of EMT. Nox1 expression was elevated in all melanoma cell lines including early radial growth phase cell line Wm3211; however, the protein level did not correlate with melanoma progression. This observation suggests that upregulation of Nox1 is an early event in melanoma transformation. In contrast, Nox4 was only detected in three metastatic cell lines, which is consistent with previous study showing that Nox4 was downstream of AKT pathway driving for melanoma invasion (Govindarajan et al., 2007) .
Studies from our laboratory and others have demonstrated that ROS levels are higher in melanoma cells than in NHMs (Meyskens et al., 1997; Sander et al., 2003; Fried and Arbiser, 2008) . The source of ROS is multiple and includes various physiological procedures or organelles, such as biosynthesis of melanin (Slominski et al., 2004) , altered tumor metabolism, and immune reactions (Komarov et al., 2005; Wittgen and van Kempen, 2007) . Our observation that Nox1 is ubiquitously overexpressed in all melanoma cell lines suggests that Nox1 overexpression may contribute to the observed high ROS levels in melanoma cells.
The subcellular localization of Nox1 is still under debate. The protein contains six transmembrane domains; therefore, it is likely a membrane protein. Here we show that a GFPtagged Nox1 protein is indeed partially localized to plasma membrane. However, the majority of the signal was localized to the cytoplasmic compartment. Further experiments are needed to determine whether the protein is localized to certain membrane organelles such as Golgi body or endoplasmic reticulum.
To understand the mechanism of Nox1-induced melanoma invasion, two key MMPs (MMP-2 and MMP-9) in melanoma invasion were examined. MMP-2 was identified as the major effector of Nox1 in melanoma invasion, which is different from that in colon cancer cells where MMP-9 was a main effector (Kim et al., 2009) . The Nox1-induced MMP-2 is likely through an ROS-dependent transcriptional mechanism, mediated by the AP-1 family transcription factors (Bergman et al., 2003; Kajanne et al., 2007; . The Nox1/AP-1/MMP-2 signal pathway is consistent with previous studies showing that AP-1 and MMP-2 played important roles in melanoma progression (Yamanishi et al., 1991; Yang and Meyskens, 2005; Malaponte et al., 2010) ; we are actively investigating the interplay between Nox gene family and AP-1 family to understand their interaction in melanomagenesis.
Nox1 regulates colon cancer cell migration through a2/a3 integrins (Sadok et al., 2009); however, it was not clear whether Nox1 induced morphological changes such as EMT, which enabled cancer cells to adapt to a different morphology and to facilitate migration and invasion. We observed that overexpression of Nox1 induced an EMT change and knockdown or inhibiting Nox1 led to a reversal of EMT, suggesting that Nox1 induced cell invasion through multiple mechanisms. Although MMPs, in particular MMP-9 and MMP-3, were able to induce EMT in some cells, MMP-2 did not show such ability in Wm3211 melanoma cells (Supplementary Figure S3b online) . Hence, the Nox1-induced cell invasion is likely through induction of MMP-2 and EMT independently.
In summary, we compared the expression of Nox1 in melanocytes and melanoma cell lines. Nox1 protein level and enzymatic activity are both higher in melanoma cells than in NHMs, suggesting that Nox1 may contribute to high ROS levels in melanoma cells. We further demonstrated that Nox1 overexpression in melanoma cells enhanced cell invasion via two seemingly independent mechanisms: (1) upregulation of MMP-2 at the transcriptional level, likely through the AP-1 transcription factor; and (2) induction of EMT. Other functions of Nox1 in NHMs and melanoma cells warrant further investigation because of its direct association with superoxide generation and hence modulating the cellular redox status and cell signaling events.
MATERIALS AND METHODS
Cell culture and invasion assay
All melanoma cell culture conditions were the same as described previously (Liu et al., 2009) . Normal human melanocytes were isolated from newborn foreskin, followed by a protocol approved by University of California Internal Review Board. Purified MMP-2 protein and GM6001 were purchased from Enzo Life Sciences (Farmingdale, NY). NAC was purchased from Sigma, St Louis, MO. The Matrigel invasion assay was carried out according to the manufacturer's instruction (Becton, Dickinson and Company, Franklin Lakes, NJ).
RT-PCR, quantitative real-time RT-PCR, and chromatin immunoprecipitation
The primers for all genes used in this study are listed in Supplementary Table S1 online. For both PCR and quantitative real-time RT-PCR, b-actin was used as internal control. The relative mRNA level was calculated by DDCt method as described before (Liu et al., 2010) . The chromatin immunoprecipitation protocol followed one described previously (Liu and Lee, 2006) .
Western blot and zymography assay
A modified protein extraction method and polyacrylamide gel system was used to analyze Nox1 protein. Cells were lysed in RIPA 250 buffer by sonication (without centrifugation) (Liu et al., 2010) . A 2 Â urea buffer (25 mM Tris, pH 6.8, 12 M urea) was added to cell lysate at 1:1 (V:V) ratio, and placed on ice for 10 minutes. The cell lysate was further mixed with a 2 Â urea loading buffer (25 mM Tris, pH 6.8, 8 M urea, 30% glycerol) and loaded to a urea-SDS-PAGE gel (containing 6 M urea) without boiling. Western blot analysis followed a standard procedure. The antibody for Nox1 was H-75, which was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Ecadherin, N-cadherin, and vimentin antibodies were obtained from www.jidonline.org 2039 BD Biosciences, San Diego, CA. a-Tubulin antibody was from Sigma. Gelatin-containing gels and developing kits were purchased from Bio-Rad (Hercules, CA). Zymography assay was performed as per the manufacturer's instruction.
DNA constructs, SEAP assay, and luciferase assay The Nox1 cDNA was purchased from Open Biosystems, Lafayette, CO. The coding region was then PCR amplified (primers: Nox1U and Nox1L) (Supplementary Table S1 online) and cloned into pEGFP-N2 vector via EcoRI and HindIII sites, resulting in pEGFP-Nox1. The pRSsh2 and pRS-sh3 were constructed from synthesized DNA oligos sh2A-sh2B and sh3A-sh3B (Supplementary Table S1 online). The MMP-2 promoter was cloned using primers prom2a and prom2b (Supplementary Table S1 online) via NheI and BglII into pGL4.10 vector, resulting in pGL4-MMP2. Dual luciferase assay was performed according to the manufacturer's instruction (Promega, Madison, WI). The pAP-1-SEAP was purchased from Clontech (Mountain View, CA) and the SEAP assay was performed using a Great EscAPe SEAP chemiluminescence detection kit from Clontech.
